We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

16 hedge funds and large institutions have $248K invested in NeuroMetrix, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

45% more funds holding

Funds holding: 1116 (+5)

21% more capital invested

Capital invested by funds: $205K → $248K (+$42.5K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
16
Holders Change
+5
Holders Change %
+45.45%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q3 2024 in Review

16 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2024, worth a combined $248K — up 21% from $205K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NURO positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Mariner, opening a new position worth an estimated $56.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $45K sold.

  • 16 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2024, up from 11 in Q2 2024.
  • Funds reported $248K of NeuroMetrix, Inc. Common Stock stock for Q3 2024, up 21% quarter-over-quarter.
  • 6 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2024 and 1 closed out, a net change of +5 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2024 was Mariner, an estimated $56.7K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2024 was Citadel Advisors, an estimated $45K sold.

Based on aggregated 13F filings for Q3 2024.